Amoxapine

FDA Approved: * May 11, 1989
Pharm Company: * WATSON LABS
Category: Antidepressant

Amoxapine, sold under the brand name Asendin among others, is a tricyclic antidepressant (TCAs). It is the N-demethylated metabolite of loxapine. Amoxapine first received marketing approval in the United States in 1992 (approximately 30 to 40 years after most of the other TCAs were introduced in the United States).[1] Contents 1 Medical uses 2 Contraindications 2.1 Lactation 3 Side effects 4 Overdose 5 Pharmacology 5.1 Pharmacodynamics 5.2 Pharmacokinetics 6 Society an... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Amoxapine DAN;25;5713
Amoxapine 25 mg Oral Tablet
NDC: 0591-5713
Labeler:
Watson Laboratories, Inc.
Amoxapine DAN;50;5714
Amoxapine 50 mg Oral Tablet
NDC: 0591-5714
Labeler:
Watson Laboratories, Inc.
Amoxapine DAN;100;5715
Amoxapine 100 mg Oral Tablet
NDC: 0591-5715
Labeler:
Watson Laboratories, Inc.
Amoxapine DAN;50;5714
Amoxapine 50 mg Oral Tablet
NDC: 54868-2438
Labeler:
Physicians Total Care, Inc.
Amoxapine 150 mg Oral Tablet
NDC: 0591-5716
Labeler:
Watson Laboratories, Inc.

Related Brands

Drugs with the same active ingredients